Infinity Pharmaceuticals vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $12 M for Infinity Pharmaceuticals, 7511 times as much (market caps of Jul 30, 2023 for Infinity Pharmaceuticals and Oct 30, 2026 for Moderna, Inc.). Infinity Pharmaceuticals's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $2 M for Infinity Pharmaceuticals.
- Both made a net loss: $40 M for Infinity Pharmaceuticals and $2.8 B for Moderna, Inc.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -2376.5% for Infinity Pharmaceuticals.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Infinity Pharmaceuticals INFI | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $12 M* | $90.1 B |
| Revenue | $2 M | $1.9 B |
| Net income | $-40 M▲ best | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jul 2023 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Infinity Pharmaceuticals or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $12 M for Infinity Pharmaceuticals, 7511 times as much (market caps of Jul 30, 2023 for Infinity Pharmaceuticals and Oct 30, 2026 for Moderna, Inc.). Infinity Pharmaceuticals's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
Which makes more money, Infinity Pharmaceuticals or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $2 M for Infinity Pharmaceuticals. Both made a net loss: $40 M for Infinity Pharmaceuticals and $2.8 B for Moderna, Inc.
Which is more profitable, Infinity Pharmaceuticals or Moderna, Inc.?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -2376.5% for Infinity Pharmaceuticals.
More about Infinity Pharmaceuticals
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.